Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indoximod + Taxane in Metastatic Breast Cancer
NCT01792050Phase 2Completed
- Sponsor
- Lumos Pharma, Inc.
- Start
- Feb 2013
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of indoximod in breast cancer, sponsored by Lumos Pharma, Inc.. Started Feb 2013; status: completed.
02
Drugs
indoximod
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01792050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01792050.